Skip to main content

Fundamentals-first equity research for GCC markets

Screener Disclosures Contact Us Privacy Policy Terms of Use

© 2026 premargin. All rights reserved.

LinkedIn X Instagram

Research updates, no noise

you@example.com Research updates, no noise

you@example.com

4016 Disclosures - Middle East Pharmaceutical Industries Company | premargin

Qatar Index10,021.90-1.4%

DFM Index5,510.99-0.1%

TASI11,078.89-0.1%

Emirates NBD27.60-3.2%

Dubai Electricity & Water Authority2.65+0.4%

EMAAR12.10-0.4%

EMAARDEV13.750.0%

ADNOC GAS3.240.0%

First Abu Dhabi Bank17.38-1.0%

Emirates Telecom18.78+0.6%

Abu Dhabi Commercial Bank12.64+0.8%

ALRAJHI104.10-0.2%

MAADEN63.70-1.2%

SABIC58.40-0.9%

Boubyan Bank0.68-0.6%

GULF BANK0.33+0.6%

Commercial Bank Of Kuwait0.47-3.3%

Burgan Bank0.210.0%

Industries Qatar10.66-1.8%

Qatar Islamic Bank22.32-1.2%

Ooredoo12.19-3.5%

Qatar Index10,021.90-1.4%

DFM Index5,510.99-0.1%

TASI11,078.89-0.1%

Emirates NBD27.60-3.2%

Dubai Electricity & Water Authority2.65+0.4%

-0.4%

EMAARDEV13.750.0%

ADNOC GAS3.240.0%

First Abu Dhabi Bank17.38-1.0%

Emirates Telecom18.78+0.6%

Abu Dhabi Commercial Bank12.64+0.8%

ALRAJHI104.10-0.2%

MAADEN63.70-1.2%

SABIC58.40-0.9%

Boubyan Bank0.68-0.6%

GULF BANK0.33+0.6%

Commercial Bank Of Kuwait0.47-3.3%

Burgan Bank0.210.0%

Industries Qatar10.66-1.8%

Qatar Islamic Bank22.32-1.2%

Ooredoo12.19-3.5%

AVALON PHARMA

Middle East Pharmaceutical Industries Company

4016StocksTadawulHealthcare

Overview Financials Dividends Disclosures

Disclosures

Market closed

SAR 98.55

Official close

+0.3%

Price as of March 29, 2026 · Market close

Prices may be delayed by up to 30 minutes.

Showing 10 of 24 results

Middle East Pharmaceutical Industries Co. Board invites its shareholders to attend the Ordinary General Assembly Meeting the (First Meeting)

Middle East Pharmaceutical Industries Company·Tadawul·Healthcare·News·March 16, 2026

Middle East Pharmaceutical Industries Co. announces the board of director’s decision to distribute cash dividends for the second half of 2025.

Middle East Pharmaceutical Industries Company·Tadawul·Healthcare·News·March 8, 2026

Middle East Pharmaceutical Industries Co. announces its Annual Financial results for the period ending on 2025-12-31

Middle East Pharmaceutical Industries Company·Tadawul·Healthcare·Financial Reports·March 4, 2026

Addendum Announcement from Middle East Pharmaceutical Industries Co. in regards to Contract Sign Off with Bio-Thera Solutions Inc.

Middle East Pharmaceutical Industries Company·Tadawul·Healthcare·News·February 4, 2026

Middle East Pharmaceutical Industries Co. Announces Contract Sign Off with Bio-Thera Solutions Inc. A global biopharmaceutical company specializing in innovative biologics and biosimilars

Middle East Pharmaceutical Industries Company·Tadawul·Healthcare·News·February 4, 2026

Middle East Pharmaceutical Industries Co. Announces the Board’s Recommendation to Increase the Capital by Granting Bouns Shares

Middle East Pharmaceutical Industries Company·Tadawul·Healthcare·News·February 1, 2026

Middle East Pharmaceutical Industries Co. announces the opening of the nomination period for the board of director’s membership for next term.

Middle East Pharmaceutical Industries Company·Tadawul·Healthcare·News·January 4, 2026

Middle East Pharmaceutical Industries Co. announces signing a non-binding Memorandum of Understanding with BENTA SAS.

Middle East Pharmaceutical Industries Company·Tadawul·Healthcare·News·November 26, 2025

Middle East Pharmaceutical Industries Co. announces its Interim Financial results for the Period Ending on 2025-09-30 ( Nine Months )

Middle East Pharmaceutical Industries Company·Tadawul·Healthcare·Financial Reports·November 5, 2025

Middle East Pharmaceutical Industries Co. announces signing a Memorandum of Understanding with The National Unified Procurement Company (NUPCO)

Middle East Pharmaceutical Industries Company·Tadawul·Healthcare·News·November 2, 2025